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The Epstein-Barr virus (EBV) latent membrane protein 2 (LMP2) is expressed in latently EBV-infected B
cells, where it forms patches in the plasma membrane and interferes with B-cell receptor signal transduction
through dominant-negative effects on protein kinases. LMP2 transcripts are detected in nasopharyngeal carci-
noma, an epithelial-cell malignancy. In this study the function of LMP2A in epithelial cells was investigated.
LMP2A was found to coprecipitate with protein kinase activities and to become phosphorylated in in vitro ki-
nase assays. Analysis of LMP2A deletion mutants demonstrated that tyrosines implicated in interacting with
Src family kinase SH2 domains and the SH2 domain of Csk, as well as the LMP2A immunoreceptor tyrosine-
based activation motif, are important for its phosphorylation in epithelial cells. LMP2A tyrosine phosphoryla-
tion was triggered by cell adhesion to extracellular-matrix (ECM) proteins. Src family kinases, whose involve-
ment in cell-ECM signaling and LMP2A phosphorylation in B lymphocytes has been well established, were
found not to be responsible for LMP2A phosphorylation in epithelial cells. Instead, coexpression of Csk, a nega-
tive Src regulator, and LMP2A led to an increase in LMP2A phosphorylation both in nonadherent cells and
upon cell adhesion. Csk also phosphorylated LMP2A in vitro. These results suggest that LMP2A has a different
role in epithelial cells, where it interacts with cell adhesion-initiated signaling pathways. Although tyrosine
phosphorylation of LMP2A occurs in both cell types, different protein kinases seem to be used: Src family ki-
nases in B lymphocytes and Csk in epithelial cells.
Epstein-Barr virus (EBV) is a ubiquitous human B-lympho-
tropic herpesvirus capable of infecting both lymphoid and ep-
ithelial cells. EBV establishes latency in B cells, with periodic
reactivation of virus and reinfection of oropharyngeal epithe-
lia. EBV is the causative agent of infectious mononucleosis
and is also associated with several human cancers, such as
the lymphoid malignancies Burkitt’s lymphoma, posttrans-
plant lymphoma, and Hodgkin’s disease, as well as nasopha-
ryngeal carcinoma (NPC), an epithelial malignancy (25, 38–41,
51). EBV latency is characterized by the absence of viral rep-
lication and the expression of specific subsets of genes. Several
types of latency can be distinguished according to the pat-
tern of viral genes that are expressed. Type I latency, found
in Burkitt’s lymphoma, has the most restricted pattern of gene
expression, with expression of EBNA1, transcripts from the
BamHI A region of the genome (5), and the EBV-encoded
RNAs (EBERs), small nonpolyadenylated RNAs of un-
known function. In immortalized B-cell lines (type III la-
tency) the nuclear antigens (EBNAs 1 through 6), EBERs,
BamHI A transcripts, and three latent membrane proteins,
LMP1, LMP2A, and LMP2B, are expressed. In type II latency,
characteristic of NPC, EBNA1, the EBERs, BamHI A tran-
scripts, LMP1, and LMP2 are expressed (25).
The focus of this study is the LMP2 gene of EBV. Two forms
of LMP2, LMP2A and LMP2B, originate from two mRNAs
that initiate from different promoters and are transcribed
across the fused terminal repeats of the viral episome (45).
They share eight common exons but differ in exon 1, which is
noncoding in LMP2B and codes for the amino terminus of
LMP2A. The proteins are highly hydrophobic, with 12 trans-
membrane domains, and aggregate in the plasma membranes
of latently infected B-lymphocytes together with LMP1 (30).
LMP2A has been suggested to regulate viral reactivation from
latency by negatively interfering with B-cell receptor signal
transduction. The LMP2A amino terminus physically interacts
with tyrosine kinases of the Src family, preferably with Lyn and
Fyn, the hemopoietic-cell-specific kinase Syk, and the mito-
gen-activated protein kinase ERK1 (6, 18–20, 29, 37). LMP2A
patches in the plasma membrane and acts as a decoy receptor
complex. The LMP2A amino terminus is thought to modulate
the activity of these signaling molecules, rendering them un-
responsive to B-cell receptor-mediated activation events, as
surface immunoglobulin (sIg) cross-linking fails to activate Lyn
and Syk protein kinases in LMP2A-expressing B cells. Fur-
ther-downstream events affected by LMP2A are inhibition
of elevation of intracellular calcium levels, prevention of
mitogen-activated protein kinase activation, and a block in the
induction of expression of the immediate-early viral transacti-
vator BZLF1, leading to suppression of viral replication in
response to sIg cross-linking (32–35). The hydrophobic 119-
amino-acid cytoplasmic amino terminus of LMP2A contains
eight tyrosine residues, several of which are in the context of
potential docking motifs for SH2 domains of cellular signaling
molecules (31, 46). Most notable is the immunoreceptor ty-
rosine-based activation motif (ITAM) surrounding tyrosines
74 and 85. ITAMs are characterized by the consensus sequence
YXX(L/I)(X6–8)YXX(L/I) and are found in associated mole-
cules of the B- and T-cell receptor signaling complexes as well
as the Fc receptor complexes (42, 50). Phosphorylated ITAMs
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serve as docking sites for the tandem SH2 domains of the
tyrosine kinases Syk and ZAP70 in B and T cells, respectively.
The inhibition of B-cell receptor-mediated signal transduction
by LMP2A has recently been shown to depend on the LMP2A
ITAM (19) and on tyrosine 112, found in the context of a
YEEA motif capable of binding to the SH2 domains of Src
family kinases (20). Other potential SH2 domain docking sites
include a YSPA sequence surrounding tyrosine 31, predicted
to bind to the SH2 domain of PLCg2, and a YSPR sequence at
tyrosine 101, which could constitute a binding site for the SH2
domain of Csk, a protein kinase that negatively regulates Src
family kinase activity (31, 46).
The function of LMP2 in epithelial cells has not been de-
termined. LMP2 is transcribed in NPC (4, 8), and NPC pa-
tients have elevated titers of antibodies to both LMP2A and
LMP2B (28), suggesting that LMP2 is expressed during some
stage of progression to disease. Additionally, LMP2 transcripts
have been detected in the permissively infected hairy leuko-
plakia lesion, a human immunodeficiency virus-associated ep-
ithelial lesion found on the lateral border of the tongue (49).
This study addresses the properties of LMP2A in epithelial
cells. Phosphorylation of LMP2A was analyzed, and the effects
of the interaction of epithelial cells with their extracellular
matrix (ECM) on LMP2A were investigated. The role of Src
family kinases in epithelial cells was also determined. The data
suggest that the role of LMP2 in epithelial cells is distinct from
that in B cells, involving functional interactions with different
signaling molecules and signaling pathways.
MATERIALS AND METHODS
Cell lines and establishment of derivatives. H1299 non-small-cell lung carci-
noma cells and 293 human kidney epithelial cells were routinely maintained in
Dulbecco’s modified Eagle medium (DMEM-H) supplemented with 10% fetal
bovine serum and antibiotics. Cells were subcultured three times per week.
Transfections of H1299 cells were performed by using the Lipofectin reagent
(Gibco-BRL) according to the manufacturer’s specifications. H1299 cell lines
expressing LMP2A and vector control cell lines were established by selection in
DMEM-H containing 200 mg of hygromycin B (Boehringer Mannheim)/ml fol-
lowing transfection with an expression construct (pMEP4) containing the
LMP2A cDNA or vector alone. Stable pools were designated H1299-LMP2A
and H1299-pMEP4, respectively. Transient transfections into 293 human kidney
epithelial cells were performed by standard calcium phosphate transfection pro-
cedures.
Plasmids and expression constructs. For transient transfections pSG5 (Strat-
agene)-derived expression constructs were used. pLMP2AHA, as well as the
LMP2A deletion mutants pLMP2AD21-36, pLMP2AD21-64, pLMP2AD21-85,
and pLMP2AD80-112, have been described previously (18, 20). In addition to the
deletion, LMP2AD80-112 contains a tyrosine-to-phenylalanine substitution at
position 74. All cDNAs are tagged with a hemagglutinin (HA) epitope at the
carboxy terminus.
For the establishment of cell lines, the wild-type LMP2A cDNA was subcloned
into the pMEP4 vector (Invitrogen) containing the hygromycin resistance gene.
This places the gene of interest under the control of the mouse metallothionein
promoter, which can be induced by the addition of heavy-metal cations. In the
experiments described here, induction was performed by the addition of 10 mM
CdCl2 for 18 to 21 h.
Antibodies and reagents. For immunoprecipitation and detection of HA-
tagged proteins, the monoclonal anti-HA antibody 12CA5 or a polyclonal an-
ti-HA antiserum (Santa Cruz) was used. The phosphotyrosine-specific antibodies
PY20 and 4G10 were purchased from Santa Cruz and Upstate Biotechnology
Inc., respectively. A monoclonal antibody to Csk and a polyclonal anti-Csk
antiserum were purchased from Transduction Labs and Santa Cruz, respectively.
ECM proteins were obtained from Collaborative Biomedical Products through
the University of North Carolina ACT core facility.
Cell adhesion experiments. Tissue culture dishes were coated with ECM
proteins at concentrations of 10 mg/ml for laminin 1, collagen, and poly-D-lysine
and 20 mg/ml for fibronectin by incubating 100- or 60-mm dishes with appropri-
ate dilutions of ECM protein in phosphate-buffered saline solution (PBS) at 4°C
overnight, followed by two washes with PBS. Adherent cells were trypsinized
briefly, the trypsin was inactivated with 0.5 mg of soybean trypsin inhibitor
(Sigma)/ml, and the cells were centrifuged and resuspended in serum-free or
complete medium. Cells were incubated in suspension at 37°C for 30 min to 1 h
with rocking before plating. After plating for various amounts of time, media and
nonadherent cells were aspirated, the plates were gently washed with cold PBS,
and the cells were lysed in Nonidet P-40 (NP-40) lysis buffer (1% NP-40, 150 mM
NaCl, 50 mM Tris-HCl [pH 7.4], 2 mM EDTA, 10 mg [each] of leupeptin and
aprotinin/ml, 2 mM phenylmethylsulfonyl fluoride, and 1 mM sodium vanadate).
Lysates were incubated on ice for 10 min, and debris was removed by centrifu-
gation in a microcentrifuge at 4°C at 10,000 3 g for 15 min. Protein concentra-
tions were determined by the Bio-Rad protein assay.
Immunoprecipitations and in vitro kinase assays. Typically, aliquots of cell
lysates containing 500 to 1,000 mg of total protein were diluted to 500 ml with
NP-40 buffer (as above). Lysates were precleared by incubation with 20 ml of
protein G-Sepharose beads for 1 h at 4°C. Supernatants were incubated with
appropriate dilutions of antibody for 1 to 4 h at 4°C before immune complexes
were captured by the addition of 20 ml of protein G-Sepharose beads for an
additional hour. Immune complexes were washed three times with 500 ml of
NP-40 buffer. For Western analysis, 25 ml of sodium dodecyl sulfate (SDS)
sample buffer was added to the immune complexes, and the proteins were
denatured by boiling for 5 min and separated by SDS-polyacrylamide gel elec-
trophoresis (PAGE).
For in vitro kinase assays, the immune complexes were washed five times in
NP-40 buffer and twice in kinase buffer (20 mM HEPES [pH 7.3] plus 5 mM
MgCl2). Kinase reactions were performed in 20 ml of kinase buffer plus 10 mM
ATP and 2.5 mCi of [g-32P]ATP. Reactions were allowed to proceed for 15 min
at room temperature and were stopped by dilution with 1 ml of cold NP-40
buffer. The reaction products were washed three more times with NP-40 buffer
before 25 ml of SDS sample buffer was added. The reaction products were
denatured by boiling for 5 min and analyzed by SDS-PAGE.
Immunoblot analysis. Proteins were transferred to an Immobilon membrane
(Millipore) in a Bio-Rad transfer unit overnight. Ponceau S staining of the
membrane was performed to ensure equal loading and transfer of proteins.
Nonspecific reactivity was blocked by incubating the membrane with Tris-buff-
ered saline solution containing 0.1% Tween 20 and 5% nonfat dry milk for 1 h
at room temperature. Tyrosine-phosphorylated proteins were detected with a
cocktail of the monoclonal antibodies 4G10 (1:1,000) and PY20 (1:300). The
12CA5 anti-HA monoclonal antibody (ascites fluid) was used at a 1:300 dilution.
Appropriate anti-mouse or anti-rabbit secondary antibodies conjugated to horse-
radish peroxidase (Amersham) were used at a dilution of 1:1,000. Detection was
performed with the Pierce Super Signal detection system according to the man-
ufacturer’s instructions.
GST-fusion protein precipitations. The glutathione S-transferase (GST)-
LMP2 fusion protein was constructed by in-frame fusion of exon 1A of the B95.8
LMP2 open reading frame to GST in the vector pGEX2TK (Pharmacia). GST
and GST-LMP2 proteins were prepared as follows. Escherichia coli DH5a trans-
formed with pGEX2TK or pGEXGST-LMP2 was grown overnight in 5-ml cul-
tures, diluted 1:20 with Luria-Bertani medium the next day, and allowed to grow
for 2 h. Then 0.1 mM isopropyl-b-D-thiogalactopyranoside (IPTG) was added for
3 h, and the cells were harvested by centrifugation and washed twice with PBS.
Cell pellets were stored at 270°C until use. Cell pellets were resuspended in 1 ml
of PBS and sonicated three times for 30 s. Debris was removed by centrifugation
in a microcentrifuge for 15 min at 10,000 3 g. GST proteins were captured by
incubation with glutathione-Sepharose beads at 4°C for 45 min, and the com-
plexes were washed three times with PBS. Induction of fusion proteins was
monitored by SDS-PAGE and staining with Coomassie brilliant blue. Equal
amounts of protein were used in precipitation experiments. Epithelial-cell lysates
were prepared in NP-40 buffer as described above and precleared by incubation
with glutathione-Sepharose beads for 2 h, followed by preclearing with GST-
Sepharose beads for 2 h. Precipitation was carried out by incubation of pre-
cleared lysates with glutathione beads, GST-Sepharose beads, or GST-LMP2–
Sepharose beads. In vitro kinase assays were performed as described above.
RESULTS
Inducible expression of LMP2A in epithelial cells. The
LMP2A cDNA was placed under the control of a heavy-metal
cation-inducible metallothionein promoter. The vector (pMEP4)
also carries genes for hygromycin acetyltransferase and the
EBV EBNA1 protein and contains the EBV origin of replica-
tion, allowing it to be maintained as an episome in transfected
cells. Following transfection into H1299 non-small-cell lung
carcinoma cells, transfectants were selected with hygromy-
cin B and resistant pools were analyzed by immunoblotting
for LMP2A expression after induction with CdCl2 (Fig. 1). In
the absence of CdCl2, the metallothionein promoter had very
little activity in this cell line.
LMP2A is associated with protein kinase activities in epi-
thelial cells. LMP2A is constitutively phosphorylated in lym-
phoblastoid cell lines and has been shown to interact with
various tyrosine kinases such as the Src family kinases Lyn and
Fyn, the hemopoietic-cell-specific kinase Syk, and the serine-
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threonine kinase ERK1 (6, 32, 37). To determine whether
LMP2A is directly associated with protein kinases in epithelial
cells, GST-fusion protein precipitation assays were performed.
The LMP2A amino terminus was fused to GST, and this fusion
protein, GST, or glutathione-Sepharose beads alone were in-
cubated with epithelial-cell lysates. The GST-LMP2 fusion
protein became heavily phosphorylated in in vitro kinase assays
performed on the precipitated protein complexes. In control
precipitations with GST protein or glutathione-Sepharose
beads alone, no phosphorylated product was detected. Figure
2A shows results of a representative experiment performed in
H1299 non-small-cell lung carcinoma cells. Identical results
were obtained with other epithelial cell lines such as ME180
and C33A (data not shown). These data indicate that LMP2A
is physically associated with protein kinase activities in epithe-
lial cells and that the LMP2A amino terminus is sufficient for
this interaction.
To confirm these results in the context of the full-length
LMP2A protein and to obtain information about phosphory-
lation and possible protein kinase interaction sites, wild-type
(WT) LMP2A and several deletion mutants, all tagged with an
HA epitope at the carboxy terminus, were transiently trans-
fected into H1299 cells and the proteins were immunoprecipi-
tated. In vitro kinase assays were carried out on the immune
complexes, and the products were resolved by SDS-PAGE
(Fig. 2B). WT LMP2A, as well as the mutants LMP2AD21-36
and LMP2AD21-64, became phosphorylated, while phosphor-
ylation of the mutants LMP2AD21-85 and LMP2AD80-112
was not detected. Phosphorylated proteins were not detected
in lysates of LMP2A-transfected cells in control precipitations
using normal mouse serum or vector-transfected cells. These
results confirm that LMP2A is constitutively associated with
one or more protein kinase activities in epithelial cells.
A diagram of the various LMP2A mutants is shown in Fig.
2C. Mutants LMP2AD21-36 and LMP2AD21-64 became phos-
phorylated at levels comparable to that of WT LMP2A. There-
fore, tyrosines 23, 31, 60, and 64, which are deleted in these two
mutants, do not seem to represent major sites of tyrosine
phosphorylation in LMP2A. LMP2AD21-85, which did not be-
come phosphorylated, has the additional deletions of tyrosines
74 and 85. These two tyrosines are found within the ITAM of
LMP2A and are important for its function in B cells (19).
Notably, LMP2AD21-85 was phosphorylated in identical ex-
periments in B lymphocytes, in contrast to our findings (20). In
the other nonphosphorylated mutant, LMP2AD80-112, tyro-
sine 74 is mutated to phenylalanine and tyrosines 85, 101, and
112 are deleted. Therefore, the ITAM is mutated, as are a
motif at tyrosine 101, YSPR, predicted to represent a dock-
ing site for the SH2 domain of Csk, and the YEEA motif
surrounding tyrosine 112, an interaction site for the SH2 do-
main of Src family kinases. This mutational analysis implicates
the ITAM as the major site for tyrosine phosphorylation, as
both mutants in which this motif was deleted did not become
phosphorylated in vitro. The predicted SH2 domain interac-
tion sites at tyrosines 101 and 112 could be involved in medi-
ating the association of protein kinases with LMP2A, although
FIG. 1. Inducible expression of LMP2A in H1299 cells. H1299 cells were
transfected with pMEP4 alone or pMEP4 containing the LMP2A cDNA tagged
with an influenza HA epitope. Transfectants were selected with hygromycin B,
and stable pools were established. LMP2A expression, controlled by the mouse
metallothionein promoter, was induced by the addition of CdCl2. Western blot-
ting was performed with the 12CA5 monoclonal anti-HA antibody.
FIG. 2. LMP2A is associated with protein kinase activities in epithelial cells. (A) GST-LMP2 interacts with protein kinases in H1299 lysates. GST and GST-LMP2
fusion proteins were incubated with H1299 cell extracts, and in vitro kinase assays with [g-32P]ATP were performed on the precipitated protein complexes.
Phosphorylated proteins were separated by SDS-PAGE and visualized by autoradiography. (B) Phosphorylation of WT LMP2A and deletion mutants after immu-
noprecipitation (IP) and an in vitro kinase assay. HA epitope-tagged LMP2A and deletion mutants were transiently transfected into H1299 cells, and the proteins were
immunoprecipitated with the monoclonal anti-HA antibody (HA) or normal mouse serum (NMS), followed by an in vitro kinase assay with [g-32P]ATP. Labeled
proteins were visualized by autoradiography. The lower panel shows expression of the deletion mutants as detected by HA Western blotting. (C) Diagram of LMP2A
deletion mutants. WT LMP2A and the deletion mutants used in this study are diagrammed with protein-protein interaction motifs. The asterisk in LMP2AD80-112
indicates a tyrosine-to-phenylalanine mutation at position 74. TM, LMP2A transmembrane domains.
VOL. 73, 1999 LMP2A PHOSPHORYLATION IN EPITHELIAL CELLS 4769
they do not seem to represent major phosphorylation sites, as
they are retained in LMP2AD21-85, which did not become
phosphorylated. Tyrosine 112 has been shown to be important
for LMP2A phosphorylation in B cells. The results presented
here suggest that tyrosine 112 has a different role in epithelial
cells.
Tyrosine phosphorylation events in LMP2A-expressing cells
in response to cell adhesion. It was of interest to determine
which epithelial-cell signaling pathways lead to LMP2A phos-
phorylation. Important aspects of epithelial-cell behavior are
regulated by the interaction of cells with their ECM. These
include control of cell shape, migration behavior, cellular pro-
liferation, cell survival, and cell differentiation. The interaction
of LMP2A with epithelial-cell signaling pathways that are ac-
tivated by cell-ECM interactions was investigated. Changes in
the tyrosine phosphorylation of several cellular proteins, such
as focal adhesion kinase and paxillin, are among the earliest
events observed upon cell adhesion (7, 26, 27).
H1299-pMEP4 and H1299-LMP2A cells were induced with
CdCl2, detached from the dishes, and replated on different
ECM substrates, and changes in tyrosine phosphorylation after
cell adhesion were monitored by Western blotting of whole-
cell lysates. The major difference between LMP2A-expressing
and vector control cells was the appearance of a heavily ty-
rosine-phosphorylated protein at 54 kDa, the molecular size of
LMP2A (Fig. 3A). This effect was observed with several dif-
ferent ECM substrates such as collagen, fibronectin, and lami-
nin 1 but did not occur when cells were nonspecifically adher-
ing to poly-D-lysine (Fig. 3B). In all experiments Western
blotting with the anti-HA monoclonal antibody confirmed that
LMP2A was expressed at equal levels at all time points (Fig.
3B and data not shown). Phosphorylation of the 54-kDa pro-
tein did not increase when the cells were kept in suspension
over the length of the time course (data not shown). These
results indicate that cell adhesion to various ECM substrates
triggers a signaling pathway that leads to tyrosine phosphory-
lation of LMP2A or of a cellular protein with a similar molec-
ular weight that is induced by LMP2A expression. This event is
probably mediated either through several cell surface recep-
tors with different specificities or through a single receptor with
pleiotropic specificities, since it occurred upon plating on dif-
ferent ECM substrates. However, the effect was not nonspe-
FIG. 3. Cell adhesion induces tyrosine phosphorylation of LMP2A in H1299 cells. (A) H1299-pMEP4 and H1299-LMP2A cells were induced with CdCl2, detached
from tissue culture dishes, and replated onto collagen, laminin 1, and fibronectin for various amounts of time. Tyrosine phosphorylation was monitored by Western
blotting. (B) Cell adhesion to poly-D-lysine does not induce LMP2A phosphorylation. H1299-pMEP4 and H1299-LMP2A cells were detached from the tissue culture
dishes and plated on poly-D-lysine-coated dishes. (Upper panel) Phosphotyrosine blot of whole-cell lysates. (Lower panel) Detection of LMP2A protein by HA Western
blotting. (C) Immunoprecipitation (IP) from lysates of LMP2A-expressing H1299 cells with polyclonal anti-HA antibodies or with normal rabbit serum (NRS) as a
negative control after cell adhesion to fibronectin for various times. LMP2A phosphorylation was detected by anti-phosphotyrosine Western blotting. (D) Analysis of
ECM-induced tyrosine phosphorylation of LMP2A deletion mutants. WT LMP2A and the LMP2A deletion mutants were transiently transfected into 293 cells, and
the cells were serum starved and either kept in suspension or plated on fibronectin-coated plates for 45 min. (Upper panel) Tyrosine phosphorylation was monitored
by immunoblotting. (Lower panel) Expression of the LMP2A deletion mutants as detected by anti-HA Western blotting. Mutants D21-36 and D21-64 became
phosphorylated upon cell adhesion, whereas D21-85 and D80-112 did not.
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cific, as an increase in LMP2A phosphorylation could not be
detected after adhesion to poly-D-lysine, a substrate that pro-
motes nonspecific cell adhesion through electrostatic interac-
tions without involvement of cell surface receptors (Fig. 3B).
Candidate receptors could be members of the integrin family.
b1 integrins, for example, can bind to several different ECM
proteins through heterodimer formation, depending on their a
subunit, and could therefore account for the different ECM
substrates that were active in our experiments. The exact na-
ture of these receptors has not yet been determined and will be
the subject of further studies.
Identification of LMP2A as the major phosphorylated pro-
tein in response to cell adhesion. The previous experiments
suggested that LMP2A becomes tyrosine phosphorylated in
response to cell adhesion. However, it is possible that LMP2A
induces the expression of a cellular protein with a molecular
weight similar to that of LMP2A whose phosphorylation is
induced upon cell-ECM interactions. To distinguish between
these two possibilities, LMP2A was immunoprecipitated from
lysates of CdCl2-induced H1299-LMP2A cells after plating on
fibronectin, and tyrosine phosphorylation was monitored by
Western blotting (Fig. 3C). Polyclonal anti-HA antibodies ef-
ficiently immunoprecipitated tyrosine-phosphorylated LMP2A,
whereas nonspecific immunoprecipitation with normal rabbit
serum did not yield any phosphorylated products. LMP2A was
only slightly phosphorylated in nonadherent cells, shown at
time zero, and the level of tyrosine phosphorylation increased
rapidly over a time course of 60 min after plating (Fig. 3C).
These data strongly suggest that the major tyrosine-phospho-
rylated protein observed in epithelial cells after cell adhesion is
LMP2A.
To correlate constitutive tyrosine phosphorylation of LMP2A
with that induced by adhesion to ECM proteins, the LMP2A
deletion mutants were transiently transfected into 293 cells.
Tyrosine phosphorylation of WT LMP2A and deletion mu-
tants after stimulation of the cells with fibronectin was moni-
tored by Western blotting. The LMP2A deletion mutants had
the same phosphorylation pattern as that observed in vitro,
with an adhesion-dependent increase in the tyrosine phosphor-
ylation of LMP2AD21-36 and LMP2AD21-64 and an absence
of phosphorylation of LMP2AD21-85 and LMP2AD80-112
(Fig. 3D).
The relationship between the LMP2A phosphorylation sta-
tus in adherent cells and its change upon cell adhesion was
investigated in more detail. Serum-starved 293 cells transiently
transfected with an LMP2A expression construct were de-
tached from the culture dish and kept in suspension or plated
on fibronectin for various amounts of time in the absence of
serum. As detected by immunoblot analysis, LMP2A was phos-
phorylated in adherent cells, while the level of tyrosine phos-
phorylation decreased upon detachment of the cells and was
nearly undetectable when the cells had been kept in suspension
for 45 min. Replating onto fibronectin-coated dishes resulted
in the expected rapid increase in LMP2A tyrosine phosphor-
ylation (Fig. 4). These results indicate that LMP2A phosphor-
ylation in epithelial cells is regulated in an adhesion-dependent
manner, and they suggest the involvement of phosphatases as
well as tyrosine kinases in this process.
To gain further insight into changes in phosphorylation lev-
els of cellular proteins in LMP2A-expressing cells, tyrosine-
phosphorylated proteins were immunoprecipitated from H1299
cell lysates at various times after adhesion to fibronectin and
detected by immunoblotting with phosphotyrosine antibodies.
The appearance of tyrosine-phosphorylated LMP2A protein
was the only observable difference between vector and LMP2A-
expressing cells. The levels and time courses of tyrosine phos-
phorylation of other proteins did not seem to be altered sig-
nificantly (Fig. 5).
Src family kinases are not involved in LMP2A phosphory-
lation in epithelial cells, a role for Csk. It has recently been
demonstrated that Y112 is required for LMP2A phosphoryla-
tion and interaction with the Src family kinase Lyn in B cells (6,
20). The model proposes that the SH2 domain of Lyn binds to
Y112, enabling Lyn to phosphorylate the ITAM, thereby cre-
ating docking sites for the tandem SH2 domains of Syk. Our
mutational analysis of LMP2A and its phosphorylation in epi-
thelial cells established a role for the ITAM in LMP2A phos-
phorylation. Tyrosines Y101 and Y112 could represent pro-
tein-protein interaction sites for LMP2A with protein kinases.
Furthermore, both Src and Fyn are known to play important
roles in cell adhesion signaling (2, 10, 13, 43). It was therefore
of interest to investigate Src family kinases as plausible candi-
dates for phosphorylating LMP2A in epithelial cells.
To determine if Src family kinases are responsible for in
vitro phosphorylation of LMP2A, LMP2A was immunopre-
cipitated from CdCl2-induced H1299-LMP2A cells and in vitro
kinase assays were performed in the presence of a Src family
kinase-specific inhibitor, PP1 (22). The 50% inhibitory concen-
tration (IC50) of PP1 for Src kinases has been reported as
between 6 and 170 nM. PP1 was able to inhibit LMP2A phos-
phorylation only at concentrations greater than 500 nM (Fig.
6A). As a control for the specificity of the compound under our
assay conditions, the epidermal growth factor receptor (EGFR)
FIG. 4. LMP2A phosphorylation in adherent and nonadherent cells. Serum-
starved transiently transfected 293 cells were lysed on the dish (ADH), kept in
suspension for the indicated times (NAD), or replated on fibronectin for the
indicated times (FN). Tyrosine phosphorylation in whole-cell lysates was moni-
tored by immunoblotting.
FIG. 5. Tyrosine phosphorylation events in LMP2A-expressing cells. Tyro-
sine-phosphorylated proteins were immunoprecipitated from H1299-pMEP4
and H1299-LMP2A cell lysates after cell adhesion to fibronectin (Fn), and
phosphorylated proteins were detected by anti-phosphotyrosine Western blot-
ting. The rightmost lane shows a phosphotyrosine blot of an immunoprecipita-
tion from adherent parental H1299 cells.
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was immunoprecipitated from EGF-stimulated H1299 cells
and autophosphorylation activity was assessed by an in vitro
kinase assay in the presence of increasing concentrations of
PP1. PP1 started to inhibit EGFR autophosphorylation at con-
centrations of 200 nM (Fig. 6B). The reported IC50 for EGFR
phosphorylation has been reported as 250 nM (22). Therefore,
PP1 is able to inhibit LMP2A phosphorylation in vitro only at
concentrations that exceed its specificity for Src family kinases.
Furthermore, we have not been able to detect a specific asso-
ciation of LMP2A and the Src family kinases Src, Fyn, and Yes,
which are expressed in epithelial cells (data not shown). These
data suggest that in epithelial cells, in contrast to results ob-
tained in B lymphocytes, the phosphorylation of LMP2A in
vitro is not dependent on Src family kinases.
To further investigate the involvement of Src family kinases
in LMP2A phosphorylation, LMP2A and Csk, a negative reg-
ulator of Src kinases (36), were coexpressed in H1299 or 293
human kidney epithelial cells. If Src kinases were responsible
for the adhesion-dependent increase in LMP2A phosphoryla-
tion, the expression of Csk would be expected to exert an inhib-
itory effect. Surprisingly, it was found that Csk overexpression
significantly increased the adhesion-dependent phosphoryla-
tion of LMP2A in H1299 cells (Fig. 7A). The level of LMP2A
tyrosine phosphorylation in nonadherent cells induced by
Csk overexpression was higher in 293 cells than in H1299
cells (Fig. 7B), most likely reflecting the increased transfection
efficiency of 293 cells.
These results suggest that Src family kinases are not involved
in the phosphorylation of LMP2A and that Csk may contribute
to LMP2A phosphorylation in response to cell adhesion. In
FIG. 6. Src family kinases do not phosphorylate LMP2A in vitro. (A) LMP2A
was immunoprecipitated from H1299-LMP2A cells induced with CdCl2. In vitro
kinase assays were performed in the presence of increasing concentrations of the
Src family-specific inhibitor PP1. (B) The EGFR was immunoprecipitated from
EGF-stimulated H1299 cells, and autophosphorylation activity was assessed by
an in vitro kinase assay in the presence of increasing concentrations of PP1.
FIG. 7. Coexpression of LMP2A and Csk leads to increased LMP2A phosphorylation after cell adhesion. (A) Transiently transfected LMP2A-expressing and
LMP2A- and Csk-coexpressing H1299 cells were detached from tissue culture dishes and replated on fibronectin (Fn) for the indicated times. Tyrosine phosphorylation
was assayed by Western blotting (upper panel). Expression of Csk was detected by anti-Csk Western blotting (lower panel). (B) Transiently transfected 293 cells,
expressing Csk, LMP2A, or both LMP2A and Csk, were plated on poly-D-lysine-coated dishes, and tyrosine phosphorylation of LMP2A was monitored by Western
blotting. No adhesion-dependent increase of tyrosine phosphorylation was detected. Note that constitutive LMP2A phosphorylation in nonadherent 293 cells is higher
than that in H1299 cells. (C) Csk and LMP2A deletion mutants were cotransfected into 293 cells, detached from tissue culture dishes, and plated on fibronectin for
the indicated times. Tyrosine-phosphorylated proteins were visualized by Western blotting. LMP2AD21-85 was not significantly phosphorylated, whereas WT LMP2A,
LMP2AD21-36, and LMP2AD21-64 showed Csk- and adhesion-dependent increases in their phosphotyrosine contents. LMP2AD80-112 was phosphorylated, but an
increase upon cell adhesion was not detected.
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agreement with this hypothesis, nonspecific adhesion of LMP2A-
and Csk-coexpressing 293 cells to poly-D-lysine did not result in
an increase in LMP2A phosphorylation, although LMP2A was
found to be phosphorylated to higher levels in nonadherent
cells than in the absence of Csk (Fig. 7B).
To further characterize Csk-mediated phosphorylation of
LMP2A, Csk and the LMP2A deletion mutants were co-
expressed in 293 cells. After plating on fibronectin, tyrosine
phosphorylation of LMP2 mutants was examined by West-
ern blotting (Fig. 7C). Again, LMP2A, LMP2AD21-36, and
LMP2AD21-64 became phosphorylated to higher levels, sug-
gesting that their phosphorylation can be induced by Csk ex-
pression. LMP2AD21-85 was not phosphorylated, in agree-
ment with the in vitro data. LMP2AD80-112, however, showed
a significant level of tyrosine phosphorylation when Csk was
coexpressed, in contrast to its behavior in vitro or when ex-
pressed alone and stimulated with fibronectin. Interestingly,
this increase in phosphotyrosine content appeared not to be
adhesion dependent (Fig. 7C), suggesting that an important
feature of LMP2A is deleted in this mutant.
To determine whether LMP2A is a substrate for Csk, Csk
was immunoprecipitated from 293 cells transiently transfected
with a Csk expression construct. The immune complexes were
incubated in in vitro kinase assays together with either GST or
a GST-LMP2 fusion protein as the substrate. Although phos-
phorylation of GST was barely detectable, GST-LMP2 was
efficiently phosphorylated (Fig. 8). In this assay no difference in
the ability to phosphorylate GST-LMP2 was observed between
Csk immunoprecipitated from nonadherent cells and Csk im-
munoprecipitated from cells stimulated with fibronectin. It has
been suggested that Csk activity for Src kinases is dependent
on the translocation of Csk to sites of Src activity and is most
likely mediated by protein-protein interactions involving the
Csk SH2 and SH3 domains (12, 17, 23, 47). If Csk acts on
LMP2A in a similar manner, an adhesion-mediated Csk acti-
vation event that relies on Csk transport to LMP2A would not
be detectable in this assay, because the GST-LMP2 fusion
protein substrate is added in solution. These data suggest that
Csk can phosphorylate LMP2A in vitro. It is also possible that
a protein kinase coprecipitating with Csk is responsible for
phosphorylation of the GST-LMP2 fusion protein.
DISCUSSION
The EBV LMP2 gene is expressed in several diseases asso-
ciated with EBV infection in both lymphoid and epithelial
tissues. Most studies have focused on the role of LMP2 in B
cells, the primary compartment of EBV latency. The role of
LMP2 in epithelial cells has not been determined. The func-
tion of LMP2 in epithelial cells and its mode of action are
likely to be different from those in B lymphocytes due to
differences in the expression of signaling molecules and the
presence and importance of different signaling pathways in
these two cell types. In B cells, LMP2A interferes with signal
transduction from the B-cell receptor complex, a cell surface
receptor protein complex that is absent in epithelial cells. Fur-
thermore, LMP2A has profound effects on the activation of the
protein kinases Lyn and Syk in response to B-cell receptor
cross-linking. Expression of both protein kinases is restricted
to cells of the lymphoid lineage. Other Src family kinases, such
as Src, Fyn, and Yes, are expressed in epithelial cells, whereas
homologs of Syk in epithelial cells have not been identified.
The experiments described in this study demonstrate that
LMP2A is tyrosine phosphorylated in epithelial cells. LMP2A
was found to be constitutively phosphorylated in adherent cells
and physically associated with protein kinase activities. Plating
of LMP2A-expressing cells on various ECM proteins resulted
in the rapid induction of LMP2A tyrosine phosphorylation.
The observation that this induction of tyrosine phosphoryla-
tion occurred both in the presence and in the absence of serum
(data not shown) strongly argues that LMP2A is phosphory-
lated by a kinase(s) that is activated upon cell-matrix interac-
tion and is not dependent on growth factor receptor signaling.
Loss of cell adhesion resulted in a rapid decrease in the phos-
photyrosine content of LMP2A, suggesting the involvement of
phosphatases in regulating this process and a requirement for
cell anchorage in maintaining LMP2A tyrosine phosphoryla-
tion in epithelial cells. Cell-ECM interaction-induced LMP2A
phosphorylation was observed with several different ECM sub-
strates but was not detectable when the cells were plated on a
nonspecific-adhesion-promoting substrate, poly-D-lysine. This
indicates that either multiple different cell surface receptors
can induce LMP2A phosphorylation or this event is mediated
by a single promiscuous receptor. Integrins are heterodimeric
cell surface receptors composed of a and b subunits, with
different heterodimers demonstrating different specificities.
The a5b1 receptor, for example, acts as a fibronectin receptor
on keratinocytes, whereas the a2b1 integrin is a collagen re-
ceptor (1, 9). Furthermore, integrins are involved in the initi-
ation and coordination of multiple signaling processes, with
induction of tyrosine phosphorylation of cellular proteins be-
ing one of the earliest events after integrin engagement (7, 11,
24, 26, 27, 43). Therefore, integrins are likely candidate recep-
tors to mediate the cell adhesion-dependent phosphorylation
of LMP2A.
LMP2A in B cells is phosphorylated by Src family kinases
which also play important roles in cell adhesion-mediated sig-
naling (10, 13, 24, 43). However, the data presented in this
study, using a Src-specific inhibitor, suggest that in epithelial
cells, LMP2A does not seem to be phosphorylated by Src
family kinases in vitro, since LMP2A phosphorylation was de-
creased only when inhibitor concentrations that are beyond the
range specific for Src kinases were reached. This result was
substantiated by the finding that expression of Csk, a negative
regulator of Src kinases, did not lead to an inhibition of adhe-
sion-mediated LMP2A phosphorylation. Unexpectedly, it was
found that Csk significantly enhanced LMP2A phosphoryla-
tion in response to stimulation with fibronectin. The latter
finding is particularly important because it argues against a
nonspecific phosphorylation event mediated by Csk. Interest-
ingly, coexpression of the focal adhesion kinase Fak, which is
rapidly activated following cell adhesion, and LMP2A did not
FIG. 8. In vitro phosphorylation of GST-LMP2 by Csk. 293 cells were tran-
siently transfected with a Csk expression construct, and Csk was immunoprecipi-
tated from unstimulated cells or cells plated on fibronectin (Fn) for 45 min. In
vitro kinase assays were performed in the presence of GST or GST-LMP2 (used
in equal amounts, as exogenous substrates) and [g-32P]ATP. Reaction products
were separated by SDS-PAGE and detected by autoradiography.
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increase LMP2A phosphorylation (data not shown). Addition-
ally, plating of LMP2A- and Csk-coexpressing cells on poly-D-
lysine did not result in an adhesion-dependent increase in
LMP2A phosphorylation, confirming the requirement for an
appropriate ECM substrate. Taken together, these results in-
dicate that Csk-mediated phosphorylation of LMP2A is not a
nonspecific phenomenon due simply to overexpression of the
kinase. In addition, Csk was able to phosphorylate a GST-
LMP2 fusion protein in vitro, demonstrating that LMP2A is a
substrate for Csk. However, it is also possible that another
kinase, coprecipitating with Csk, might be responsible for
phosphorylation of the GST-LMP2 fusion protein.
The role of Csk in cell adhesion-mediated signaling is not
well understood. Csk has been demonstrated to physically in-
teract with the cytoskeletal protein paxillin as well as the focal
adhesion kinase Fak (48). These protein-protein interactions
might be responsible for bringing Csk into the proximity of
sites of Src activity, which is also found in focal adhesions. Csk
phosphorylates Src at a C-terminal tyrosine, thereby creating a
docking site within Src for the Src SH2 domain. The intramo-
lecular interaction which occurs leads to a closed, inactive
conformation (14). It will be important to determine the func-
tional interactions among LMP2A, Csk, Src, and focal adhe-
sion proteins, their phosphorylation, and their activities upon
cell adhesion.
Investigation of LMP2A deletion mutants indicated that the
same regions that are important for LMP2A function in B cells
are important for its phosphorylation in epithelial cells. Mu-
tants with deletions of the ITAM, Y112, and Y101, a possible
Csk SH2 domain-binding site, did not become phosphorylated
in vitro and upon cell adhesion. One difference from B lym-
phocytes was that the mutant LMP2AD21-85, which was found
to be phosphorylated and associated with Src kinases in B cells
(20), was not phosphorylated in epithelial cells. Studies in B
cells further established tyrosine Y112 as important for
LMP2A phosphorylation (20). This suggests a different role for
the YEEA motif surrounding tyrosine Y112 in epithelial cells.
In addition, LMP2AD80-112 was not phosphorylated in B cells
but was found to be phosphorylated in epithelial cells when
Csk was overexpressed. These results suggest that an interac-
tion of the Csk SH2 domain at Y101 might be required to allow
specific LMP2A phosphorylation at the ITAM when only en-
dogenous Csk is present. In the presence of overexpressed Csk,
LMP2A may be nonspecifically phosphorylated at other resi-
dues without a requirement for an interaction of the Csk SH2
domain with Y101 of LMP2A. The fact that an adhesion-
dependent increase in phosphorylation of LMP2AD80-112 was
not observed indicates that an important feature of LMP2A is
deleted in this mutant. Interestingly, tyrosine 74, part of the
ITAM, is found in the context of a YQP motif. The C-terminal
tyrosines of Src kinases, such as Src, Lck, Fyn, and Yes, which
are phosphorylated by Csk, are likewise found within a YQP
sequence, although the surrounding residues bear little homol-
ogy to the sequence surrounding Y74 in LMP2A. The analysis
of point mutants will clarify if Y74 indeed represents a phos-
phorylation site for Csk. A physical interaction between Csk
and LMP2A is likely to be very weak, since Csk protein was not
detected in LMP2A immunoprecipitates (data not shown).
However, a stable association of Csk with its known substrates
Src and Lck has likewise not been detected (3, 44). The pos-
sibility that other unidentified kinases physically interact with
LMP2A and phosphorylate it in vitro is not excluded.
Cell-ECM interactions play an important role in regulating
epithelial-cell behavior. In squamous epithelium, for example,
ECM receptors such as integrins are predominantly expressed
in the basal proliferating cell layer, where contact with the
basement membrane occurs. Differentiating cells detach from
the basement membrane and form the upper layers of the
epithelium. At the same time, integrin expression is downregu-
lated and the cellular proliferative capacity is lost (1, 21). It is
conceivable that LMP2A expression interferes with or en-
hances several aspects of ECM signaling, altering signals and
keeping the epithelial cell in a state that is beneficial for the
virus. Prevention of differentiation, for example, would allow
the virus to persist and replicate in a cell that does not undergo
the biochemical changes that take place during differentiation
and result in metabolically dead cells that are sloughed off at
the surface of the epithelium. It has been reported that expres-
sion of LMP1 in keratinocytes or keratinocyte cell lines can
inhibit epithelial-cell differentiation (15, 16). It will be inter-
esting to see if LMP2A can further modulate or alter epithe-
lial-cell differentiation, possibly through a functional interplay
with LMP1.
Cell-ECM interactions also play important roles in the reg-
ulation of cell migration and, in the case of neoplastic cells, in
cell invasion and metastasis (43). These processes are pro-
foundly affected by integrin expression and signaling. Epithe-
lial malignancies often display altered levels of integrin expres-
sion, with up- or downregulation of specific members of the
family, and in multiple systems these effects correlate with
altered migration or invasive behavior. As NPC is a highly
invasive cancer, it is possible that the expression of LMP2 in
NPC contributes to the invasive phenotype by altering signals
from the ECM. It will be important to determine the exact
molecular processes that are affected by LMP2 expression in
epithelial cells in order to understand LMP2 function in this
cell type.
The results presented in this study strongly suggest that
there is a function for LMP2 in epithelial cells and that, in
analogy to the scenario in B cells, it seems to affect cellular
signal transduction processes. The final outcome of impinging
on these processes is likely to be different in B cells and epi-
thelial cells, demonstrating how the virus can adapt to different
cellular environments and alter cell behavior to its advantage,
using the same molecule with a different function in a different
context.
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